Down-regulation of serum high- mobility group box 1 protein in patients with pulmonary tuberculosis and nontuberculous mycobacterial lung disease

Su Young Kim, Won Jung Koh, Hye Yun Park, Kyeongman Jeon, Soo Youn Lee, Jae Joon Yim, SungJae Shin

Research output: Contribution to journalArticle

Abstract

Background: Recently, increased levels of high-mobility group box 1 protein (HMGB1) have been identified in various inflammatory conditions and infections. However, no studies have evaluated the HMGB1 level in nontuberculous mycobacterial (NTM) lung disease, and compared it to mycobacterial lung disease. Methods: A total of 60 patients newly diagnosed with NTM lung disease, 44 culture-positive pulmonary tuberculosis (TB) patients, and 34 healthy controls, were included in this study. The serum HMGB1 concentrations were quantified using HMGB1 enzyme-linked immunosorbent assay kits. Results: Serum HMGB1 level in patients with pulmonary TB or NTM lung disease, was significantly lower than that of the healthy controls. In addition, the serum HMGB1 level in TB patients was significantly lower than patients with NTM lung disease. However, the levels in NTM patient subgroups did not differ according to the causative species, disease progression, and disease phenotype. Conclusion: Although low levels of serum HMGB1 has the potential to be a marker of mycobacterial lung disease, these levels were unable to differentiate disease progression and disease phenotype in NTM lung diseases.

Original languageEnglish
Pages (from-to)153-158
Number of pages6
JournalTuberculosis and Respiratory Diseases
Volume80
Issue number2
DOIs
Publication statusPublished - 2017 Apr 1

Fingerprint

HMGB1 Protein
Pulmonary Tuberculosis
Lung Diseases
Down-Regulation
Serum
Disease Progression
Phenotype
Tuberculosis
Enzyme-Linked Immunosorbent Assay
Infection

All Science Journal Classification (ASJC) codes

  • Pulmonary and Respiratory Medicine
  • Infectious Diseases

Cite this

Kim, Su Young ; Koh, Won Jung ; Park, Hye Yun ; Jeon, Kyeongman ; Lee, Soo Youn ; Yim, Jae Joon ; Shin, SungJae. / Down-regulation of serum high- mobility group box 1 protein in patients with pulmonary tuberculosis and nontuberculous mycobacterial lung disease. In: Tuberculosis and Respiratory Diseases. 2017 ; Vol. 80, No. 2. pp. 153-158.
@article{b9c0900299a7482bbfa98a7ac3772662,
title = "Down-regulation of serum high- mobility group box 1 protein in patients with pulmonary tuberculosis and nontuberculous mycobacterial lung disease",
abstract = "Background: Recently, increased levels of high-mobility group box 1 protein (HMGB1) have been identified in various inflammatory conditions and infections. However, no studies have evaluated the HMGB1 level in nontuberculous mycobacterial (NTM) lung disease, and compared it to mycobacterial lung disease. Methods: A total of 60 patients newly diagnosed with NTM lung disease, 44 culture-positive pulmonary tuberculosis (TB) patients, and 34 healthy controls, were included in this study. The serum HMGB1 concentrations were quantified using HMGB1 enzyme-linked immunosorbent assay kits. Results: Serum HMGB1 level in patients with pulmonary TB or NTM lung disease, was significantly lower than that of the healthy controls. In addition, the serum HMGB1 level in TB patients was significantly lower than patients with NTM lung disease. However, the levels in NTM patient subgroups did not differ according to the causative species, disease progression, and disease phenotype. Conclusion: Although low levels of serum HMGB1 has the potential to be a marker of mycobacterial lung disease, these levels were unable to differentiate disease progression and disease phenotype in NTM lung diseases.",
author = "Kim, {Su Young} and Koh, {Won Jung} and Park, {Hye Yun} and Kyeongman Jeon and Lee, {Soo Youn} and Yim, {Jae Joon} and SungJae Shin",
year = "2017",
month = "4",
day = "1",
doi = "10.4046/trd.2017.80.2.153",
language = "English",
volume = "80",
pages = "153--158",
journal = "Tuberculosis and Respiratory Diseases",
issn = "1738-3536",
publisher = "The Korean Academy of Tuberculosis and Respiratory Diseases",
number = "2",

}

Down-regulation of serum high- mobility group box 1 protein in patients with pulmonary tuberculosis and nontuberculous mycobacterial lung disease. / Kim, Su Young; Koh, Won Jung; Park, Hye Yun; Jeon, Kyeongman; Lee, Soo Youn; Yim, Jae Joon; Shin, SungJae.

In: Tuberculosis and Respiratory Diseases, Vol. 80, No. 2, 01.04.2017, p. 153-158.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Down-regulation of serum high- mobility group box 1 protein in patients with pulmonary tuberculosis and nontuberculous mycobacterial lung disease

AU - Kim, Su Young

AU - Koh, Won Jung

AU - Park, Hye Yun

AU - Jeon, Kyeongman

AU - Lee, Soo Youn

AU - Yim, Jae Joon

AU - Shin, SungJae

PY - 2017/4/1

Y1 - 2017/4/1

N2 - Background: Recently, increased levels of high-mobility group box 1 protein (HMGB1) have been identified in various inflammatory conditions and infections. However, no studies have evaluated the HMGB1 level in nontuberculous mycobacterial (NTM) lung disease, and compared it to mycobacterial lung disease. Methods: A total of 60 patients newly diagnosed with NTM lung disease, 44 culture-positive pulmonary tuberculosis (TB) patients, and 34 healthy controls, were included in this study. The serum HMGB1 concentrations were quantified using HMGB1 enzyme-linked immunosorbent assay kits. Results: Serum HMGB1 level in patients with pulmonary TB or NTM lung disease, was significantly lower than that of the healthy controls. In addition, the serum HMGB1 level in TB patients was significantly lower than patients with NTM lung disease. However, the levels in NTM patient subgroups did not differ according to the causative species, disease progression, and disease phenotype. Conclusion: Although low levels of serum HMGB1 has the potential to be a marker of mycobacterial lung disease, these levels were unable to differentiate disease progression and disease phenotype in NTM lung diseases.

AB - Background: Recently, increased levels of high-mobility group box 1 protein (HMGB1) have been identified in various inflammatory conditions and infections. However, no studies have evaluated the HMGB1 level in nontuberculous mycobacterial (NTM) lung disease, and compared it to mycobacterial lung disease. Methods: A total of 60 patients newly diagnosed with NTM lung disease, 44 culture-positive pulmonary tuberculosis (TB) patients, and 34 healthy controls, were included in this study. The serum HMGB1 concentrations were quantified using HMGB1 enzyme-linked immunosorbent assay kits. Results: Serum HMGB1 level in patients with pulmonary TB or NTM lung disease, was significantly lower than that of the healthy controls. In addition, the serum HMGB1 level in TB patients was significantly lower than patients with NTM lung disease. However, the levels in NTM patient subgroups did not differ according to the causative species, disease progression, and disease phenotype. Conclusion: Although low levels of serum HMGB1 has the potential to be a marker of mycobacterial lung disease, these levels were unable to differentiate disease progression and disease phenotype in NTM lung diseases.

UR - http://www.scopus.com/inward/record.url?scp=85018282233&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018282233&partnerID=8YFLogxK

U2 - 10.4046/trd.2017.80.2.153

DO - 10.4046/trd.2017.80.2.153

M3 - Article

AN - SCOPUS:85018282233

VL - 80

SP - 153

EP - 158

JO - Tuberculosis and Respiratory Diseases

JF - Tuberculosis and Respiratory Diseases

SN - 1738-3536

IS - 2

ER -